Cliff Asness's ABBV Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.15 M shares of AbbVie Inc. (ABBV) worth $262.93 M, representing 0.14% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 2.85 M shares. Largest reduction occurred in Q2 2015, reducing 3.26 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +223,904 | Add 24.16% | 1.15 M | $228.49 |
| Q3 2025 | +328,850 | Add 54.99% | 926,842 | $226.20 |
| Q2 2025 | -176,114 | Reduce 22.75% | 597,992 | $183.49 |
| Q1 2025 | -674,261 | Reduce 46.55% | 774,106 | $205.97 |
| Q4 2024 | -263,367 | Reduce 15.39% | 1.45 M | $176.91 |
| Q3 2024 | +307,306 | Add 21.88% | 1.71 M | $194.69 |
| Q2 2024 | -134,055 | Reduce 8.71% | 1.4 M | $169.33 |
| Q1 2024 | -306,614 | Reduce 16.62% | 1.54 M | $181.01 |
| Q4 2023 | +348,011 | Add 23.25% | 1.85 M | $154.78 |
| Q3 2023 | +331,662 | Add 28.46% | 1.5 M | $149.06 |
| Q2 2023 | -28,800 | Reduce 2.41% | 1.17 M | $133.05 |
| Q1 2023 | -227,583 | Reduce 16.01% | 1.19 M | $158.06 |
| Q4 2022 | -36,141 | Reduce 2.48% | 1.42 M | $161.03 |
| Q3 2022 | -208,400 | Reduce 12.51% | 1.46 M | $134.21 |
| Q2 2022 | -131,592 | Reduce 7.32% | 1.67 M | $151.90 |
| Q1 2022 | -232,348 | Reduce 11.44% | 1.8 M | $162.11 |
| Q4 2021 | +57,832 | Add 2.93% | 2.03 M | $135.40 |
| Q3 2021 | +103,628 | Add 5.55% | 1.97 M | $107.87 |
| Q2 2021 | -387,539 | Reduce 17.18% | 1.87 M | $111.88 |
| Q1 2021 | -205,311 | Reduce 8.34% | 2.26 M | $107.71 |
| Q4 2020 | -1.21 M | Reduce 32.96% | 2.46 M | $105.63 |
| Q3 2020 | -1.65 M | Reduce 31.05% | 3.67 M | $86.90 |
| Q2 2020 | +2.3 M | Add 75.82% | 5.33 M | $96.16 |
| Q1 2020 | +1.26 M | Add 70.99% | 3.03 M | $76.16 |
| Q4 2019 | +623,364 | Add 54.29% | 1.77 M | $88.41 |
| Q3 2019 | -1.79 M | Reduce 60.91% | 1.15 M | $75.32 |
| Q2 2019 | -2.04 M | Reduce 40.98% | 2.94 M | $72.03 |
| Q1 2019 | +950,737 | Add 23.62% | 4.98 M | $80.42 |
| Q4 2018 | -967,494 | Reduce 19.38% | 4.03 M | $92.19 |
| Q3 2018 | +931,390 | Add 22.93% | 4.99 M | $94.58 |
| Q2 2018 | -938,798 | Reduce 18.77% | 4.06 M | $93.50 |
| Q1 2018 | +507,695 | Add 11.30% | 5 M | $94.65 |
| Q4 2017 | +752,859 | Add 20.13% | 4.49 M | $96.71 |
| Q3 2017 | +2.85 M | Add 318.01% | 3.74 M | $88.86 |
| Q2 2017 | -46,033 | Reduce 4.89% | 894,791 | $72.51 |
| Q1 2017 | +347,710 | Add 58.62% | 940,824 | $65.16 |
| Q4 2016 | -63,576 | Reduce 9.68% | 593,114 | $62.62 |
| Q3 2016 | +132,726 | Add 25.33% | 656,690 | $63.07 |
| Q2 2016 | -544,432 | Reduce 50.96% | 523,964 | $61.91 |
| Q1 2016 | -283,076 | Reduce 20.95% | 1.07 M | $57.12 |
| Q4 2015 | +125,319 | Add 10.22% | 1.35 M | $59.24 |
| Q3 2015 | -2.24 M | Reduce 64.64% | 1.23 M | $54.41 |
| Q2 2015 | -3.26 M | Reduce 48.45% | 3.47 M | $67.19 |
| Q1 2015 | +2.72 M | Add 67.83% | 6.73 M | $58.54 |
| Q4 2014 | +1.5 M | Add 59.88% | 4.01 M | $65.44 |
| Q3 2014 | -773,075 | Reduce 23.57% | 2.51 M | $57.76 |
| Q2 2014 | +314,100 | Add 10.59% | 3.28 M | $56.44 |
| Q1 2014 | +1.95 M | Add 192.90% | 2.97 M | $51.40 |
| Q4 2013 | +703,435 | Add 227.54% | 1.01 M | $52.81 |
| Q3 2013 | +309,147 | New Buy | 309,147 | $44.73 |
Cliff Asness's AbbVie Investment FAQs
Cliff Asness first purchased AbbVie Inc. (ABBV) in Q3 2013, acquiring 309,147 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held AbbVie Inc. (ABBV) for 50 quarters since Q3 2013.
Cliff Asness's largest addition to AbbVie Inc. (ABBV) was in Q3 2017, adding 3,740,301 shares worth $332.36 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,150,746 shares of AbbVie Inc. (ABBV), valued at approximately $262.93 M.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.14% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in AbbVie Inc. (ABBV) was 6,726,677 shares, as reported at the end of Q1 2015.